Are Transfusions a Barrier to High-Quality End-of-Life Care in Hematology?
Dr. LeBlanc and Dr. Litzow take a look at an issue within the field consisting of hematologists referring their patients to hospice late or not at all even when there are s
Remission: More Than Meets the Eye
Dr. Teachey reviews a study that suggests that patients in morphologic remission but with high minimal residual disease have inferior outcomes.
Invited opinion pieces written by leaders of the hematology community.
The information presented in the Op-Eds for The Hematologist does not necessarily represent the opinions, beliefs, or positions of The Hematologist and/or the American Society of Hematology. The Hematologist is not responsible for any errors or omissions in the materials; reliance on any information presented is solely at your own risk. The Hematologist welcomes Op-Ed pieces or letters of up to 200 words to the editor on any subject, and will publish based on editorial decisions regarding interest to readers and space availability. These Op-Eds may also be edited for reasons of space and clarity. Send your letters to Managing Editor Juana Llorens at firstname.lastname@example.org.
Dr. Belinda Avalos provides an update on how the Standing Committee on Promoting Diversity is advising ASH in its efforts to improve minority recruitment into hematology research and practice in the U.S. and Canada.
Dr. George and Dr. Gullapalli provide a thorough synopsis of the history of Theranos, a medical and technological innovations laboratory company founded by Elizabeth Holmes.
Dr. Alexis Thompson makes a thorough assessment of the latest clinical practice guidelines for sickle cell disease.
Dr. Cynthia Dunbar, Dr. Janis Abkowitz, Dr. Nancy Berliner, and Dr.
Susan Shurin discuss the concerted grassroots effort to nominate women
for ASH awards.
Congresswoman Louise Slaughter discusses the provisions of the bill she sponsored that protects the privacy of patients who undergo genetic testing.
Dr. Barry Coller discusses the concept of the physician as discoverer, highlighting how this model has been eroded by changes in medical education and training and suggesting measures that can be taken to restore it.
As both a part-time hematologist and mother, Dr. Lanie Francis shares advice on achieving success and satisfaction at home and at the office.
Dr. Meir Preis explains how new standards for resident duty hours may affect the organization of inpatient teaching services.
The fact is nearly all constituent communications are counted and responded to by Members of Congress and their staff. While it is true that individualized communications with some expression of personal sentiment or opinion are most likely to be influential, nearly all legislators do use constituent communications as a gauge of public opinion and integrate it into their decision-making.
Community-based private hematology practices are a valuable resource for the care and treatment of many patients with hematologic problems. Unfortunately, hematologists have recently seen a rapid increase in what had been a slow erosion of the incentives to enter and remain in such practices.
July-August 2018Volume 15, Issue 4
A new Compendium providing updated clinical information to "Ask the Hematologist" articles published in The Hematologist from 2010 to 2015 is now available.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology